UPDATE 3-Lilly's breast cancer drug combination succeeds key study By: Reuters: Company News March 20, 2017 at 10:07 AM EDT * To submit marketing application for mono, combo therapy in 2017 Read More >> Related Stocks: Eli Lilly Novan Inc Pfizer